Amna Nawaz:
Judy, one of the vital debated items of the invoice is an settlement that might permit the federal government by means of Medicare to barter costs with pharmaceutical corporations on sure medication beginning in 2025.
It could additionally cap out-of-pocket prices for seniors at $2,000 a yr, beginning in 2024. For diabetic sufferers, out-of-pocket prices for insulin could be capped at $35 for a 30-day provide That is beginning in 2023.
To assist us perceive extra concerning the impression of this and its limits, I am joined by Stacie Dusetzina, affiliate professor of well being coverage at Vanderbilt College Faculty of Drugs.
Professor, welcome to the “NewsHour.” Thanks for making the time.
That key provision on this proposal, the flexibility to barter for prescription drug costs, we all know some Democrats needed Medicare to have the ability to try this with many extra medication, as much as 250 medication. That was considerably scaled again on this invoice.
Inform me about that and the impression you thru that can have.
